Journal of Heterocyclic Chemistry p. 229 - 239 (2000)
Update date:2022-08-05
Topics:
Grozinger, Karl G.
Byrne, Denis P.
Nummy, Laurence J.
Ridges, Michael D.
Salvagno, Annette
Nevirapine (1) is a non-nucleoside reverse transcriptase inhibitor marketed for HIV treatment by Boehringer Ingelheim as Viramune since 1996. In vitro studies of nevirapine biotransformation using human liver microsomes demonstrated the formation of five major metabolites. This paper describes the syntheses of these metabolites.
View MoreHangzhou Mole's Science & Technology Co.,Ltd.(expird)
Contact:+86-571-56880228
Address:15F Guodu development Building, NO.182 Zhaohui Road
Hefei Highzone Fine Chemical S&T CO.,LTD
Contact:86-0551-63663560
Address:room 1801 NO. 24 Shuguang RD.
Hangzhou Showland Technology Co., Ltd.
Contact:86-571-88920516
Address:ROOM2118,NO.553,WENSAN ROAD,HANGZHOU,CHINA
Contact:0086-22-23410962
Address:17-201, Ningfuli, Shuishanggongyuandong road,Nankai district, Tianjin, China
Yantai Derun Liquid Crystal Materials Co. Ltd.
website:http://www.ytderun.com
Contact:86-535-6300169
Address:ROOM 90, XIANGFU STREET, FUSHAN NEW-HIGH-TECH IDUSTRY ZONE, YANTAI
Doi:10.1016/j.tet.2017.02.061
(2017)Doi:10.1016/S0040-4020(03)00770-1
(2003)Doi:10.1039/b000600i
(2000)Doi:10.1016/j.catcom.2010.02.007
(2010)Doi:10.1039/b807704e
(2008)Doi:10.1002/1521-3765(20010601)7:11<2332::AID-CHEM23320>3.0.CO;2-W
(2001)
